3-哌啶苯甲醛 | 669050-72-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: 3-哌啶苯甲醛
• 英文名称: 3-(piperidin-1-yl)benzaldehyde
• 英文别名: 3-Piperidinobenzaldehyde；3-piperidin-1-ylbenzaldehyde
• CAS: 669050-72-0
• 化学式: C₁₂H₁₅NO
• 分子量: 189.257
• InChiKey: FXXQUTSXXILOMY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2933399090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Piperidinobenzaldehyde
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Piperidinobenzaldehyde
CAS number: 669050-72-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C12H15NO
Molecular weight: 189.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  Ethyl 4-amino-4-(2,6-dimethoxyphenyl)-2-methylbutanoate 、 3-哌啶苯甲醛 生成 5-(2,6-dimethoxyphenyl)-3-methyl-1-(3-(piperidin-1-yl)benzyl)pyrrolidin-2-one
  参考文献：
  名称：

  Lactam derivatives useful as orexin receptor antagonists

  摘要：

  本发明涉及公式(I)的内酰胺衍生物，其中Y，R1，R2和R3如描述中所述，它们的制备，其药学上可接受的盐以及它们作为药物的用途，含有一个或多个公式（I）化合物的药物组合物，特别是它们作为促进睡眠药物的用途。

  公开号：

  US09242970B2

文献信息

• NOVEL INHIBITORS
  申请人：Heiser Ulrich

  公开号：US20110092501A1

  公开（公告）日：2011-04-21

  The invention relates to novel pyrrolidine derivatives of formula (I): wherein R 1 , R 2 and R 3 are as defined herein, as inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5). QC catalyzes the intramolecular cyclization of N-terminal glutamine residues into pyroglutamic acid (5-oxo-prolyl, pGlu*) under liberation of ammonia and the intramolecular cyclization of N-terminal glutamate residues into pyroglutamic acid under liberation of water.

  本发明涉及新颖的吡咯烷衍生物，其具有如下公式(I)：其中R1、R2和R3如本文所述定义，作为谷氨酰胺环化酶（QC，EC 2.3.2.5）的抑制剂。谷氨酰胺环化酶催化N末端谷氨酰胺残基形成焦谷氨酸（5-氧代脯氨酸，pGlu*）的分子内环化，并释放氨，以及催化N末端谷氨酸残基形成焦谷氨酸的分子内环化，并释放水。
• A Gold-Catalyzed Domino Cyclization Enabling Rapid Construction of Diverse Polyheterocyclic Frameworks
  作者：Yi He、Zhenghua Li、Koen Robeyns、Luc Van Meervelt、Erik V. Van der Eycken

  DOI：10.1002/anie.201710592

  日期：2018.1.2

  We report herein an efficient gold(I)‐catalyzed post‐Ugi domino dearomatization/ipso‐cyclization/Michael sequence that enables access to libraries of diverse (hetero)arene‐annulated tricyclic heterocycles. This process affords novel complex polycyclic scaffolds in moderate to good yields from readily available acyclic precursors with excellent chemo‐, regio‐, and diastereoselectivity. The power of

  我们在此报告的有效金（I） -催化后的Ugi多米诺脱芳构化/本位-cyclization /迈克尔序列，使访问不同的（杂）的文库芳烃-环三环杂环。该方法从容易获得的具有良好化学，区域和非对映选择性的无环前体中以中等到良好的产率提供了新型复杂的多环支架。通过在两个操作步骤中快速合成40个具有吲哚，吡咯，（苯并）呋喃，（苯并）噻吩，吡唑和富电子芳烃基团的40个高度官能化的多杂环化合物，证明了该策略的强大功能。
• [EN] LACTAM DERIVATIVES USEFUL AS OREXIN RECEPTOR ANTAGONISTS<br/>[FR] DÉRIVÉS DE LACTAME UTILES EN TANT QU'ANTAGONISTES DU RÉCEPTEUR DE L'OREXINE
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2012063207A1

  公开（公告）日：2012-05-18

  The present invention relates to lactam derivatives of formula (I) wherein Y, R1, R2 and R3 are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as orexin receptor antagonists.

  本发明涉及公式（I）的内酰胺衍生物，其中Y、R1、R2和R3如描述中所述，以及它们的制备方法，其药学上可接受的盐，以及它们作为药物的用途，包括含有一个或多个公式（I）化合物的药物组合物，特别是它们作为促进睡眠的药物受体拮抗剂的用途。
• [EN] ANALOGS OF DEHYDROPHENYLAHISTINS<br/>[FR] ANALOGUES DE DÉSHYDROPHÉNYLAHISTINES
  申请人：NEREUS PHARMACEUTICALS INC

  公开号：WO2011084962A1

  公开（公告）日：2011-07-14

  Analogs of dehydrophenylahistins are disclosed as are methods for making such compounds. Compositions and methods for treating various disease conditions including cancer and non-cancer diseases associated with vascular proliferation are also disclosed.

  揭示了脱氢苯酚组合物的类似物，以及制备这类化合物的方法。还揭示了用于治疗包括癌症和与血管增殖有关的非癌症疾病等各种疾病状况的组合物和方法。
• [EN] NOVEL INHIBITORS OF BACTERIAL GLUTAMINYL CYCLASES FOR USE IN THE TREATMENT OF PERIODONTAL AND RELATED DISEASES<br/>[FR] NOUVEAUX INHIBITEURS DE GLUTAMINYL-CYCLASES BACTÉRIENNES DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DE PARODONTOPATHIES ET DE MALADIES ASSOCIÉES
  申请人：FRAUNHOFER GES FORSCHUNG

  公开号：WO2019162458A1

  公开（公告）日：2019-08-29

  The present invention relates to novel compounds which are particularly useful as inhibitors of bacterial glutaminyl cyclases (bacQC); pharmaceutical compositions comprising such compounds; compounds and/or pharmaceutical compositions for use in methods for treatment, in particular for use in the treatment of periodontitis and related conditions; as well as to crystals comprising bacterial glutaminyl cyclases, methods for identifying candidate compounds which may associate with the binding pocket of a bacQC and/or are bacQC inhibitors.

  本发明涉及一种新型化合物，特别适用于作为细菌谷氨酰环化酶（bacQC）的抑制剂；包括这种化合物的药物组合物；用于治疗方法的化合物和/或药物组合物，特别是用于治疗牙周炎及相关疾病的治疗方法；以及包括细菌谷氨酰环化酶的晶体，用于识别可能与bacQC的结合口袋相关联或是bacQC抑制剂的候选化合物的方法。